Previous close | 5.25 |
Open | N/A |
Bid | 22.50 |
Ask | 27.00 |
Strike | 95.00 |
Expiry date | 2026-01-16 |
Day's range | 5.25 - 5.25 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.